Cited by 89Childhood Cancer Survivors' Quality of LifeAcute Lymphoblastic Leukemia researchCancer-related cognitive impairment studies

Neurocognitive Outcome in Very Long‐Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only

Kanellopoulos, Adriani, Andersson, Stein, Zeller, Bernward, Tamnes, Christian K., Fjell, Anders M., Walhovd, Kristine B., Westlye, Lars T., Fosså, Sophie D. +1 more·2016·Pediatric Blood & Cancer

Abstract

Background There is a concern regarding long-term cognitive late effects after treatment for acute lymphoblastic leukemia (ALL). The present study assessed neuropsychological function in very long-term childhood ALL survivors treated with chemotherapy only. We also investigated associations between neurocognitive performance and individual treatment load. Procedure One-hundred and twelve adult ALL survivors, diagnosed 1970-2002 before age 16 and treated with chemotherapy only, and 100 comparison peers underwent neuropsychological tests covering processing speed, executive functions, working memory, and verbal learning and memory. Individual cumulative doses of cytostatic agents were extracted from the medical records for each patient. Results Mean age at diagnosis for survivors was 6.3 years and mean follow-up time was 22.6 years. There was no difference in general intellectual ability between survivors and comparison peers. However, survivors performed significantly more poorly in the neurocognitive domains' processing speed (P = 0.003, Cohen's d 0.48), executive functions, and working memory (both P 1.5 SD below control mean) for processing speed was 22%, executive functions 31%, working memory 34%, and verbal learning and memory 16%. Comparing survivors with poor versus normal neurocognitive performance, we found no difference with respect to cumulative doses of any of the cytostatic agents, age at diagnosis, or gender. Conclusions Very long-term survivors of childhood ALL…

Integrity signals

Registry

Crossref · 10.1002/pbc.25690

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Available studies often evaluate outcomes in adult survivors of childhood leukemia.

    “Firstly, available studies often evaluate outcomes in adult survivors of childhood leukemia (Blaauwbroek et al., 2007; Edelmann et al., 2014; Kanellopoulos et al., 2015; Tamnes et al., 2015; Zeller et al., 2013).”

    From Brain structure, working memory and response inhibition in childhood leukemia survivors (2017) · cites this paper as Kanellopoulos et al., 2015

The citation lists haven’t been fetched yet

References 44 · Cited by 89

Authors
Kanellopoulos, A., Andersson, S., Zeller, B., Tamnes, C. K., Fjell, A. M., Walhovd, K. B., Westlye, L. T., Fosså, S. D., & Ruud, E.
Affiliations
  • Oslo University Hospital (NO)
  • University of Oslo (NO)
Corresponding author
Kanellopoulos, Adriani
Venue
Pediatric Blood & Cancer
Publisher
Wiley
Published
2015-08-27
Volume
63
Issue
1
Pages
133-138
ISSN
  • 1545-5009 (ISSN-L)
  • 1545-5017
OpenAlex
W1532342469
Cited by
89
References
44
Citations by year
2026: 5 · 2025: 6 · 2024: 10 · 2023: 4 · 2022: 7 · 2021: 10 · 2020: 10 · 2019: 6 · 2018: 15 · 2017: 8 · 2016: 7
FWCI
9.99
Type
journal article
Language
en
Open access
closed
Locations
  • Pediatric Blood & Cancer (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Helse SørØst HF (2009016)
  • Norwegian Cancer Society
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Acute Lymphoblastic Leukemia research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
Keywords
childhood acute lymphoblastic leukemia, long-term survivors, neurocognitive function, late effects of cancer treatment, chemotherapy, processing speed, executive function, working memory, verbal learning and memory, intellectual ability, treatment burden
MeSH terms
Adolescent, Antineoplastic Agents, Child, Female, Humans, Male, Memory, Short-Term, Neuropsychological Tests, Verbal Learning, Treatment Outcome, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Young Adult, Executive Function

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review